文献速递肝病消化道肿瘤与早癌

肿瘤浸润CD8+ T细胞PD1表达水平与肝细胞癌特征之间的关联

Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma.
PubMed 文献 · Gastroenterology · 2018-08-24

研究纳入90例在Asan Medical Center手术切除的肝细胞癌患者,分析肿瘤浸润CD8+ T细胞PD1表达水平与基因表达、细胞因子产生及肝癌侵袭性的关系。PD1-high CD8+ T细胞表达TIM3和LAG3、产生IFNG和TNF最低,存在离散PD1-high细胞群的肝癌更具侵袭性,且体外联合阻断PD1与TIM3或LAG3可进一步恢复增殖和细胞因子产生。

要点

  • PD1-high CD8+ T细胞表达TIM3和LAG3,产生IFNG和TNF最低。
  • 存在离散PD1-high细胞群的肝癌比无此群的肝癌更具侵袭性。
  • 联合阻断PD1与TIM3或LAG3可进一步恢复CD8+ T细胞增殖和细胞因子产生。

核心结论

  • 肝细胞癌标本中存在表达不同水平PD1的CD8+ T细胞,存在离散PD1-high CD8+ T细胞群的肝癌可能对联合免疫检查点阻断治疗更敏感。

研究设计与样本

  • 研究纳入90例于2016年4月至2018年4月在Asan Medical Center(韩国首尔)接受手术切除的肝细胞癌患者,获取肝癌标本、邻近非肿瘤组织和血液样本。
  • 用流式细胞术分析肝内淋巴细胞和肿瘤浸润T细胞,并按PD1表达水平分选为PD1-high、PD1-intermediate和PD1-negative三群。
  • 对分选细胞进行RNA测序,检测抗CD3刺激后CD8+ T细胞的增殖及干扰素γ(IFNG)和肿瘤坏死因子(TNF)产生。
  • 用HLA-A*0201 dextramer鉴定肿瘤相关抗原特异性CD8+ T细胞,用免疫组化评估肿瘤组织PDL1表达。

主要发现

  • PD1-high、PD1-intermediate和PD1-negative CD8+ T细胞具有不同的基因表达谱,PD1-high细胞表达更高水平的T细胞耗竭调控基因。
  • PD1-high细胞表达TIM3和LAG3,TCF1+、TBEThigh/eomesoderminlow和CD127+比例低。
  • PD1-high细胞在抗CD3刺激下产生IFNG和TNF的量最低。
  • 存在离散PD1-high细胞群的肝癌比无离散PD1-high细胞群的肝癌更具侵袭性。
  • 存在离散PD1-high细胞群的肝癌具有更高水平的抗PD1治疗应答预测生物标志物。

关键数值与推荐

  • PD1-high细胞表达TIM3和LAG3,TCF1+、TBEThigh/eomesoderminlow和CD127+比例低。
  • PD1-high细胞在抗CD3刺激下产生IFNG和TNF的量最低。
  • 存在离散PD1-high细胞群的肝癌具有更高水平的抗PD1治疗应答预测生物标志物。

临床怎么用

  • 作者认为存在离散PD1-high CD8+ T细胞群的肝癌可能对联合免疫检查点阻断治疗更敏感。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: T-cell exhaustion, or an impaired capacity to secrete cytokines and proliferate with overexpression of immune checkpoint receptors, occurs during chronic viral infections but has also been observed in tumors, including hepatocellular carcinomas (HCCs). We investigated features of exhaustion in CD8+ T cells isolated from HCC specimens. METHODS: We obtained HCC specimens, along with adjacent nontumor tissues and blood samples, from 90 patients who underwent surgical resection at Asan Medical Center (Seoul, Korea) from April 2016 through April 2018. Intrahepatic lymphocytes and tumor-infiltrating T cells were analyzed by flow cytometry. Tumor-infiltrating CD8+ T cells were sorted by flow cytometry into populations based on expression level of programmed cell death 1 (PDCD1 or PD1): PD1-high, PD1-intermediate, and PD1-negative. Sorted cells were analyzed by RNA sequencing. Proliferation and production of interferon gamma (IFNG) and tumor necrosis factor (TNF) by CD8+ T cells were measured in response to anti-CD3 and antibodies against immune checkpoint receptors including PD1, hepatitis A virus cellular receptor 2 (HAVCR2 or TIM3), lymphocyte activating 3 (LAG3), or isotype control. Tumor-associated antigen-specific CD8+ T cells were identified using HLA-A*0201 dextramers. PDL1 expression on tumor tissue was assessed by immunohistochemistry. RESULTS: PD1-high, PD1-intermediate, and PD1-negative CD8+ T cells from HCCs had distinct gene expression profiles. PD1-high cells expressed higher levels of genes that regulate T-cell exhaustion than PD1-intermediate cells. PD1-high cells expressed TIM3 and LAG3, and low proportions of TCF1+, TBEThigh/eomesoderminlow, and CD127+. PD1-high cells produced the lowest amounts of IFNG and TNF upon anti-CD3 stimulation. Differences in the PD1 expression patterns of CD8+ T cells led to the identification of 2 subgroups of HCCs: HCCs with a discrete population of PD1-high cells were more aggressive than HCCs without a discrete population of PD1-high cells. HCCs with a discrete population of PD1-high cells had higher levels of predictive biomarkers of response to anti-PD1 therapy. Incubation of CD8+ T cells from HCCs with a discrete population of PD1-high cells with antibodies against PD1 and TIM3 or LAG3 further restored proliferation and production of IFNG and TNF in response to anti-CD3. CONCLUSIONS: We found HCC specimens to contain CD8+ T cells that express different levels of PD1. HCCs with a discrete population of PD1-high CD8+ T cells express TIM3 and/or LAG3 and produce low levels of IFNG and TNF in response to anti-CD3. Incubation of these cells with antibodies against PD1 and TIM3 or LAG3 further restore proliferation and production of cytokines; HCCs with a discrete population of PD1-high CD8+ T cells might be more susceptible to combined immune checkpoint blockade-based therapies.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Kim HD, Song GW, Park S, et al. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma. Gastroenterology. 2018. PMID: 30145359. doi:10.1053/j.gastro.2018.08.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。